Caitong International Asset Management Co., LTD Roivant Sciences Ltd. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 67 shares of ROIV stock, worth $763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 4,324
98.45%
Holding current value
$763
Previous $51.2 Million
98.68%
% of portfolio
0.0%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$749 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$705 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$524 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$464 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$409 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.02B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...